di-Potasio hidrogenofosfato trihidrato ≥99%, en cristales
Proveedor: MP Biomedicals
Sinónimos:
Potasio fosfato disódico trihidrato
02151946.1
02151946.5
0215194610
0215194601
ICNA02151946.1EA
38.5
EUR
ICNA02151946.1
ICNA02151946.5
ICNA0215194610
ICNA0215194601
di-Potasio hidrogenofosfato trihidrato ≥99%, en cristales
di-Potasio hidrogenofosfato trihidrato
Soluble in water (100 mg/ml) ; Insoluble to slightly soluble in ethanol; insoluble in alcohol.
For phosphate buffers, the pH increases with decreasing temperature. Compared with a buffer at 25 °C, buffers at 4 °C will be 0,08 pH unit higher and a buffer at 37 °C will be 0,025 pH unit lower. The concentration of phosphate also influences pH. ; Typical Buffer Preparation/Formulations: 1 M Potassium Phosphate Monobasic, 1 M Potassium Phosphate Dibasic, 5 M Sodium Chloride
Formula:
K₂HPO₄·3H₂O MW: 228,22 g/mol Pto. de fusión: 340 °C Densidad: 2,3 g/cm³ (20 °C) Temperatura de almacenaje: Ambiente |
Número MDL:
MFCD00149926 Núm. CAS: 16788-57-1 EINECS: 231-834-5 Índice Merck: 13,07743 |
Resultados test especificaciones
Form | Clear Granular Crystals |
Storage | Store at room temperature (15 to 30 °C) |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...